These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders. Plosker GL; Sorkin EM Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326 [TBL] [Abstract][Full Text] [Related]
30. Effect of quinapril therapy on blood pressure and serotonin change in patients with mild to moderate hypertension. Huang JL; Cheng FC; Chen YT; Ting CT Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov; 58(5):329-34. PubMed ID: 9037848 [TBL] [Abstract][Full Text] [Related]
31. Evidence for a functional tissue renin-angiotensin system in the rat mesenteric vasculature and its involvement in regulating blood pressure. Weishaar RE; Panek RL; Major TC; Simmerman J; Rapundalo ST; Taylor DG J Pharmacol Exp Ther; 1991 Feb; 256(2):568-74. PubMed ID: 1847201 [TBL] [Abstract][Full Text] [Related]
32. Differential secretion and removal of multiple renin forms. Shier DN; Malvin RL Am J Physiol; 1985 Jul; 249(1 Pt 2):R79-84. PubMed ID: 3893166 [TBL] [Abstract][Full Text] [Related]
33. Effects of quinapril, a new angiotensin-converting enzyme inhibitor, on vasoconstrictor activity in the isolated, perfused mesenteric vasculature of hypertensive rats. Major TC; Overhiser RW; Taylor DG; Panek RL J Pharmacol Exp Ther; 1993 Apr; 265(1):187-93. PubMed ID: 8474005 [TBL] [Abstract][Full Text] [Related]
34. Resolution of rat renin substrates by isoelectric focusing. Faiers AA; Loh AY; Osmond DH Can J Biochem; 1977 Aug; 55(8):869-75. PubMed ID: 19143 [TBL] [Abstract][Full Text] [Related]
35. Different production and decay rates of six renin forms isolated from rat plasma. Sessler FM; Jacquez JA; Malvin RL Am J Physiol; 1986 May; 250(5 Pt 1):E551-7. PubMed ID: 3518486 [TBL] [Abstract][Full Text] [Related]
36. Effects of the angiotensin-converting enzyme inhibitor quinapril on renal function in rats. Graziano MJ; Dethloff LA; Griffin HE; Pegg DG Arch Int Pharmacodyn Ther; 1993; 324():87-104. PubMed ID: 8297189 [TBL] [Abstract][Full Text] [Related]
37. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus. Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494 [TBL] [Abstract][Full Text] [Related]
38. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects. Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397 [TBL] [Abstract][Full Text] [Related]
39. Hemodynamic effects of quinapril, a novel angiotensin-converting enzyme inhibitor. Gupta RK; Kjeldsen SE; Krause L; Kneisley J; Posvar E; Weder AB; Julius S Clin Pharmacol Ther; 1990 Jul; 48(1):41-9. PubMed ID: 2196144 [TBL] [Abstract][Full Text] [Related]
40. A new sensitive direct radioimmunoassay for human plasma renin and its clinical application. Higaki J; Ogihara T; Imai N; Kumahara Y; Hontani S; Nishiura M; Ogawa H; Hirose S; Murakami K J Lab Clin Med; 1984 Dec; 104(6):947-54. PubMed ID: 6389735 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]